INNOVATION1 BIOTECH INC. (IVBT) Financial Statements
INNOVATION1 BIOTECH INC. (IVBT) files with the U.S. Securities and Exchange Commission under CIK 0001629205. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2023
- Revenue
- $0
- Net Income
- -$5.99 million
- Total Assets
- $75.99 thousand
- Net Cash from Operations
- -$620.20 thousand
Fiscal year ended Aug 31, 2023. Latest periodic SEC filing: May 6, 2025. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for IVBT in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History